These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies. Schwerk A; Alves FD; Pouwels PJ; van Amelsvoort T J Neurochem; 2014 Jan; 128(1):1-87. PubMed ID: 23937509 [TBL] [Abstract][Full Text] [Related]
48. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Moore GJ Pediatr Radiol; 1998 Nov; 28(11):805-14. PubMed ID: 9799306 [TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance spectroscopy in metabolic disorders. Rossi A; Biancheri R Neuroimaging Clin N Am; 2013 Aug; 23(3):425-48. PubMed ID: 23928198 [TBL] [Abstract][Full Text] [Related]
50. Proton Magnetic Resonance Spectroscopy in Post-Traumatic Stress Disorder-Updated Systematic Review and Meta-Analysis. Swanberg KM; Campos L; Abdallah CG; Juchem C Chronic Stress (Thousand Oaks); 2022; 6():24705470221128004. PubMed ID: 36237981 [TBL] [Abstract][Full Text] [Related]
51. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430 [TBL] [Abstract][Full Text] [Related]
52. Evidence of altered metabolism of cellular membranes in bipolar disorder comorbid with post-traumatic stress disorder. Jabbari-Zadeh F; Cao B; Stanley JA; Liu Y; Wu MJ; Tannous J; Lopez M; Sanches M; Mwangi B; Zunta-Soares GB; Soares JC J Affect Disord; 2021 Jun; 289():81-87. PubMed ID: 33951550 [TBL] [Abstract][Full Text] [Related]
53. Post-traumatic stress disorder affects fucose-α(1-2)-glycans in the human brain: preliminary findings of neuro deregulation using in vivo two-dimensional neuro MR spectroscopy. Quadrelli S; Tosh N; Urquhart A; Trickey K; Tremewan R; Galloway G; Rich L; Lea R; Malycha P; Mountford C Transl Psychiatry; 2019 Jan; 9(1):27. PubMed ID: 30659168 [TBL] [Abstract][Full Text] [Related]
54. Proton magnetic resonance spectroscopy in schizophrenia. Bertolino A; Weinberger DR Eur J Radiol; 1999 May; 30(2):132-41. PubMed ID: 10401594 [TBL] [Abstract][Full Text] [Related]
55. Dietary-free glutamate: implications for research on fear-overconsolidation and PTSD. Bracha HS; Chronicle EP CNS Spectr; 2006 Jan; 11(1):14-5. PubMed ID: 16496463 [No Abstract] [Full Text] [Related]
56. Metabolic alterations in generalised anxiety disorder: a review of proton magnetic resonance spectroscopic studies. Delvecchio G; Stanley JA; Altamura AC; Brambilla P Epidemiol Psychiatr Sci; 2017 Dec; 26(6):587-595. PubMed ID: 28789715 [TBL] [Abstract][Full Text] [Related]
57. Quantitative in vivo neurochemical profiling in humans: where are we now? McKay J; Tkáč I Int J Epidemiol; 2016 Oct; 45(5):1339-1350. PubMed ID: 27794521 [TBL] [Abstract][Full Text] [Related]
58. Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Cecil KM Neuroimaging Clin N Am; 2013 Aug; 23(3):381-92. PubMed ID: 23928195 [TBL] [Abstract][Full Text] [Related]
59. Molecular Neuroimaging in Posttraumatic Stress Disorder. Im JJ; Namgung E; Choi Y; Kim JY; Rhie SJ; Yoon S Exp Neurobiol; 2016 Dec; 25(6):277-295. PubMed ID: 28035179 [TBL] [Abstract][Full Text] [Related]
60. Recent advances in magnetic resonance neurospectroscopy. Rosen Y; Lenkinski RE Neurotherapeutics; 2007 Jul; 4(3):330-45. PubMed ID: 17599700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]